Concepedia

Frederick Millard

FM

29

Publications

1.8K

Citations

19

H-Index

1987

Active since

Affiliations

University of California San Diego(Current)

Dana-Farber Cancer Institute

Memorial Sloan Kettering Cancer Center

Naval Medical Center San Diego

University of California, San Francisco

Frederick Millard is an author at University of California San Diego specializing in oncology, medicine, and radiation oncology.

ORCID

Top concepts

Publications per year

1987–2022

29

Publications

29

Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP

Robert McMillan, P Tani, Frederick Millard et al. · Blood · 1987 · 312 citations · Full text

Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

Peter F. Coccia, Alberto S. Pappo, Lynda K. Beaupin et al. · Journal of the National Comprehensive Cancer Network · 2018 · 292 citations

, , +23

Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma

Matthew I. Milowsky, Christian Dittrich, Ignacio Durán et al. · European Journal of Cancer · 2014 · 111 citations

, , +6

Feasibility and efficacy of neoadjuvant sunitinib before nephron‐sparing surgery

Jonathan Silberstein, Frederick Millard, Reza Mehrazin et al. · British Journal of Urology · 2010 · 104 citations

Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B

Hedy L. Kindler, Frederick Millard, James E. Herndon et al. · Lung Cancer · 2001 · 101 citations

, , +9

Rows per page

1–5 of 29